Skip to main content
logo
Lin BioScience, Inc. (TPEX:6696)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
939.00
0.00 (0.00%)
Aug 19, 2026, 2:59 PM CST

Lin BioScience Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
77,77532,84210,8128,94612,58312,832
Market Cap Growth
495.04%203.77%20.85%-28.90%-1.94%83.66%
Enterprise Value
76,23830,1558,4977,78811,31411,817
Last Close Price
939.00397.00136.58113.24170.33180.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.041.312.022.617.2528.33
P/TBV Ratio
7.423.093.954.4111.1828.87

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.030.01
Net Debt / Equity Ratio
-0.65-0.65-0.97-0.94-0.92-1.78
Net Debt / EBITDA Ratio
4.175.713.572.953.612.39
Net Debt / FCF Ratio
7.2311.235.053.174.172.76
Quick Ratio
37.5457.6833.6623.7020.601.72
Current Ratio
38.0858.1834.4524.6920.941.74
Return on Equity (ROE)
-21.83%-16.93%-28.66%-41.08%-41.98%-70.57%
Return on Assets (ROA)
-15.73%-11.54%-19.97%-25.16%-20.05%-19.74%
Return on Capital Employed (ROCE)
-15.50%-11.40%-27.10%-31.70%-25.10%-74.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.07%-4.15%-6.88%-7.68%-2.49%-3.39%
FCF Yield
-2.94%-4.41%-9.48%-11.34%-3.05%-2.27%
Buyback Yield / Dilution
-3.48%-4.46%-6.24%-3.14%-4.27%-10.73%